New strategy for developing universal flu vaccine
A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic–2009's H1N1 […]
» Read moreHome » Antibodies »
Physiologically, milk contains biocomponents that are highly protective against infections. In light of this, the AGR-149-Infectious Diseases group at the […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19) pandemic, is highly transmutable and infectious. […] According to research from the University of California, some cases of severe coronavirus disease 2019 (COVID-19) may be related to […] Biorbyt is delighted to have been honoured with a Queen’s Award for Enterprise for its outstanding achievements in international trade. […] Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses […] Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard […] Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody […] People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […] The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […]
New research focuses on cow's milk as a possible source of COVID-19 control
A novel multiplexed diagnostic approach for COVID-19
Previous H3N2 influenza A infection may explain some cases of severe COVID-19
Biorbyt receives Queen’s Award for Enterprise
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages
Scientists unveil new Ebola virus vaccine design
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
